Co-diagnostics, inc. ceo to deliver keynote address at marketsandmarkets 2024 in london, england

Salt lake city, utah , march 18, 2024 /prnewswire/ -- co-diagnostics, inc. (nasdaq: codx) (the "company" or "co-dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that co-dx ceo dwight egan will deliver the keynote address at the 5th annual infectious disease diagnostics and molecular diagnostics conference, organized by marketsandmarkets and held march 21-22, 2024, in london, england. mr. egan will be delivering the keynote presentation at 9:00 am local time on march 21, and will be discussing impacts that the company's upcoming co-dx pcr platform* is anticipated to have on the future of diagnostics accessibility.
CODX Ratings Summary
CODX Quant Ranking